|
G
|
Gap43
|
growth associated protein 43
|
increases expression multiple interactions
|
ISO
|
isophthalate analog results in increased expression of GAP43 mRNA; isophthalate analog results in increased expression of GAP43 protein Go 6976 inhibits the reaction [isophthalate analog results in increased expression of GAP43 protein]
|
CTD |
PMID:23643828 |
|
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797
|
|
G
|
Prkca
|
protein kinase C, alpha
|
multiple interactions affects localization
|
ISO
|
Go 6976 inhibits the reaction [isophthalate analog affects the localization of PRKCA protein]
|
CTD |
PMID:23643828 |
|
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
|
|
|
G
|
Acly
|
ATP citrate lyase
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of ACLY mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACLY mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631
|
|
G
|
Acot1
|
acyl-CoA thioesterase 1
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of ACOT1 mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACOT1 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749
|
|
G
|
Acox1
|
acyl-CoA oxidase 1
|
multiple interactions decreases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACOX1 mRNA tetrachloroisophthalonitrile results in decreased expression of ACOX1 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
|
|
G
|
Acta2
|
actin alpha 2, smooth muscle
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of ACTA2 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
EXP
|
tetrachloroisophthalonitrile binds to and results in increased activity of AHR protein
|
CTD |
PMID:14636698 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
G
|
Angpt4
|
angiopoietin 4
|
multiple interactions
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of ANGPT4 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 3:140,420,389...140,454,213
Ensembl chr 3:160,880,728...160,913,921
|
|
G
|
Ano1
|
anoctamin 1
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile results in increased expression of ANO1 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 1:209,180,755...209,329,413
Ensembl chr 1:209,180,755...209,329,550
|
|
G
|
Bad
|
BCL2-associated agonist of cell death
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile results in increased expression of BAD mRNA
|
CTD |
PMID:34549778 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile results in increased expression of BAX protein tetrachloroisophthalonitrile results in increased expression of BAX mRNA
|
CTD |
PMID:30586609 PMID:34549778 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of BCL2 protein
|
CTD |
PMID:30586609 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Bmp15
|
bone morphogenetic protein 15
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of BMP15 protein
|
CTD |
PMID:30586609 |
|
NCBI chr X:18,840,943...18,846,006
Ensembl chr X:18,840,829...18,847,438
|
|
G
|
Casp3
|
caspase 3
|
increases activity increases expression
|
ISO
|
tetrachloroisophthalonitrile results in increased activity of CASP3 protein tetrachloroisophthalonitrile results in increased expression of CASP3 mRNA
|
CTD |
PMID:34549778 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile results in increased expression of CASP8 mRNA
|
CTD |
PMID:34549778 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of CCL2 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
G
|
Ccl4
|
C-C motif chemokine ligand 4
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of CCL4 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
|
|
G
|
Cftr
|
CF transmembrane conductance regulator
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of CFTR protein [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of CFTR protein; [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of CFTR mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643
|
|
G
|
Cldn1
|
claudin 1
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of CLDN1 mRNA; tetrachloroisophthalonitrile results in decreased expression of CLDN1 protein
|
CTD |
PMID:34549778 |
|
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529
|
|
G
|
Col1a1
|
collagen type I alpha 1 chain
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of COL1A1 mRNA; tetrachloroisophthalonitrile metabolite results in increased expression of COL1A1 protein
|
CTD |
PMID:32289622 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of CPT1A mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of CPT1A mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
|
|
G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of CXCL2 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of CYP11A1 protein
|
CTD |
PMID:30586609 |
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
G
|
Defa5
|
defensin alpha 5
|
multiple interactions
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of DEFA5 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318
|
|
G
|
Dgat1
|
diacylglycerol O-acyltransferase 1
|
multiple interactions decreases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of DGAT1 mRNA tetrachloroisophthalonitrile results in decreased expression of DGAT1 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016
|
|
G
|
Dgat2
|
diacylglycerol O-acyltransferase 2
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of DGAT2 mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of DGAT2 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:162,866,237...162,896,566
|
|
G
|
Dio1
|
iodothyronine deiodinase 1
|
decreases activity
|
ISO
|
tetrachloroisophthalonitrile results in decreased activity of DIO1 protein
|
CTD |
PMID:29228274 PMID:30561685 |
|
NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:127,303,083...127,319,771
|
|
G
|
Dio2
|
iodothyronine deiodinase 2
|
decreases activity
|
ISO
|
tetrachloroisophthalonitrile results in decreased activity of DIO2 protein
|
CTD |
PMID:30561685 |
|
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
|
|
G
|
Dio3
|
iodothyronine deiodinase 3
|
decreases activity
|
ISO
|
tetrachloroisophthalonitrile results in decreased activity of DIO3 protein
|
CTD |
PMID:30561685 |
|
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
decreases phosphorylation
|
ISO
|
tetrachloroisophthalonitrile results in decreased phosphorylation of EGFR protein
|
CTD |
PMID:28426875 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
increases activity
|
ISO
|
tetrachloroisophthalonitrile results in increased activity of ERBB2 protein
|
CTD |
PMID:11222871 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
G
|
Fabp1
|
fatty acid binding protein 1
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of FABP1 mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of FABP1 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113
|
|
G
|
Fasn
|
fatty acid synthase
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of FASN mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of FASN mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
G
|
Fshr
|
follicle stimulating hormone receptor
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of FSHR protein
|
CTD |
PMID:30586609 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:10,952,329...11,160,288
|
|
G
|
Gck
|
glucokinase
|
multiple interactions decreases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of GCK mRNA tetrachloroisophthalonitrile results in decreased expression of GCK mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
|
|
G
|
Gdf9
|
growth differentiation factor 9
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of GDF9 protein
|
CTD |
PMID:30586609 |
|
NCBI chr10:38,090,021...38,100,801
Ensembl chr10:38,089,878...38,100,797
|
|
G
|
Gja1
|
gap junction protein, alpha 1
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of GJA1 protein
|
CTD |
PMID:30586609 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
G
|
Gpam
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
multiple interactions decreases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of GPAM mRNA tetrachloroisophthalonitrile results in decreased expression of GPAM mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911
|
|
G
|
Hsd17b4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of HSD17B4 protein
|
CTD |
PMID:30586609 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:45,515,373...45,604,467
|
|
G
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of HSD3B1 protein
|
CTD |
PMID:30586609 |
|
NCBI chr 2:188,858,574...188,864,694
|
|
G
|
Il1a
|
interleukin 1 alpha
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of IL1A mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
G
|
Il1b
|
interleukin 1 beta
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of IL1B mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il6
|
interleukin 6
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of IL6 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Ins1
|
insulin 1
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of INS1 protein [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of INS1 protein
|
CTD |
PMID:33246813 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
G
|
Klf4
|
KLF transcription factor 4
|
multiple interactions increases expression
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of KLF4 mRNA tetrachloroisophthalonitrile results in increased expression of KLF4 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases phosphorylation
|
ISO
|
tetrachloroisophthalonitrile results in decreased phosphorylation of MAPK1 protein
|
CTD |
PMID:28426875 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases phosphorylation
|
ISO
|
tetrachloroisophthalonitrile results in decreased phosphorylation of MAPK3 protein
|
CTD |
PMID:28426875 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
increases phosphorylation
|
ISO
|
tetrachloroisophthalonitrile results in increased phosphorylation of MAPK8 protein
|
CTD |
PMID:34549778 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
G
|
Mep1b
|
meprin A subunit beta
|
multiple interactions increases expression
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of MEP1B mRNA tetrachloroisophthalonitrile results in increased expression of MEP1B mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr18:12,641,041...12,667,759
Ensembl chr18:12,641,041...12,667,755
|
|
G
|
Mif
|
macrophage migration inhibitory factor
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in decreased expression of MIF mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
G
|
Mlxip
|
MLX interacting protein
|
multiple interactions
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in increased expression of MLXIP mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr12:33,128,524...33,192,300
Ensembl chr12:38,789,404...38,853,059
|
|
G
|
Mmp1
|
matrix metallopeptidase 1
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in decreased expression of MMP1 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
G
|
Mmp3
|
matrix metallopeptidase 3
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in decreased expression of MMP3 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of MMP9 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
G
|
Mttp
|
microsomal triglyceride transfer protein
|
multiple interactions
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of MTTP mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:229,286,501...229,327,650
|
|
G
|
Muc1
|
mucin 1, cell surface associated
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile results in increased expression of MUC1 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
G
|
Muc17
|
mucin 17, cell surface associated
|
multiple interactions
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of MUC17 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr12:25,139,076...25,175,249
|
|
G
|
Muc2
|
mucin 2, oligomeric mucus/gel-forming
|
increases expression decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in increased expression of MUC2 mRNA tetrachloroisophthalonitrile results in decreased expression of MUC2 protein [tetrachloroisophthalonitrile co-treated with procymidone] results in decreased expression of MUC2 protein
|
CTD |
PMID:33246813 |
|
NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:206,229,035...206,261,280
|
|
G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases activity
|
ISO
|
tetrachloroisophthalonitrile results in increased activity of NR1I2 protein
|
CTD |
PMID:20143881 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
G
|
Ocln
|
occludin
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of OCLN mRNA
|
CTD |
PMID:34549778 |
|
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
G
|
Pklr
|
pyruvate kinase L/R
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of PKLR mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PKLR mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644
|
|
G
|
Pla2g4a
|
phospholipase A2 group 4A
|
multiple interactions
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of PLA2G4A mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of PPARA mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARA mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of PPARG mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARG mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of PTGS2 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Rad51
|
RAD51 recombinase
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile results in increased expression of RAD51 protein
|
CTD |
PMID:30586609 |
|
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:126,554,190...126,579,469
|
|
G
|
S100a8
|
S100 calcium binding protein A8
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of S100A8 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221
|
|
G
|
S100a9
|
S100 calcium binding protein A9
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in decreased expression of S100A9 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870
|
|
G
|
Scd
|
stearoyl-CoA desaturase
|
multiple interactions decreases expression
|
ISO
|
[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of SCD1 mRNA tetrachloroisophthalonitrile results in decreased expression of SCD1 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
G
|
Slc12a2
|
solute carrier family 12 member 2
|
multiple interactions
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of SLC12A2 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
|
|
G
|
Slc26a3
|
solute carrier family 26 member 3
|
multiple interactions increases expression
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of SLC26A3 mRNA tetrachloroisophthalonitrile results in increased expression of SLC26A3 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 6:53,751,415...53,792,300
Ensembl chr 6:53,751,415...53,792,294
|
|
G
|
Slc26a6
|
solute carrier family 26 member 6
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile results in increased expression of SLC26A6 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 8:118,438,110...118,448,271
Ensembl chr 8:118,438,180...118,448,270
|
|
G
|
Slc27a2
|
solute carrier family 27 member 2
|
decreases expression multiple interactions
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of SLC27A2 mRNA [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of SLC27A2 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 3:134,258,101...134,295,581
Ensembl chr 3:134,258,101...134,295,581
|
|
G
|
Slc9a3
|
solute carrier family 9 member A3
|
multiple interactions increases expression
|
ISO
|
[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of SLC9A3 mRNA tetrachloroisophthalonitrile results in increased expression of SLC9A3 mRNA
|
CTD |
PMID:33246813 |
|
NCBI chr 1:30,953,215...30,996,209
Ensembl chr 1:30,953,216...30,996,002
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
decreases activity
|
ISO
|
tetrachloroisophthalonitrile results in decreased activity of TGFB1 protein
|
CTD |
PMID:31652400 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tjp1
|
tight junction protein 1
|
decreases expression
|
ISO
|
tetrachloroisophthalonitrile results in decreased expression of TJP1 mRNA
|
CTD |
PMID:34549778 |
|
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
G
|
Tlr4
|
toll-like receptor 4
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of TLR4 mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
G
|
Tnf
|
tumor necrosis factor
|
increases expression
|
ISO
|
tetrachloroisophthalonitrile metabolite results in increased expression of TNF mRNA
|
CTD |
PMID:32289622 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
|
G
|
Acadl
|
acyl-CoA dehydrogenase, long chain
|
decreases expression
|
ISO
|
di-n-hexyl phthalate results in decreased expression of ACADL mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:75,783,689...75,822,164
|
|
G
|
Acadm
|
acyl-CoA dehydrogenase medium chain
|
decreases expression
|
ISO
|
di-n-hexyl phthalate results in decreased expression of ACADM mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864
|
|
G
|
Acsl1
|
acyl-CoA synthetase long-chain family member 1
|
decreases expression
|
ISO
|
di-n-hexyl phthalate results in decreased expression of ACSL1 mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023
|
|
G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of ALDH2 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
G
|
Ar
|
androgen receptor
|
multiple interactions
|
ISO
|
di-n-hexyl phthalate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; di-n-hexyl phthalate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]
|
CTD |
PMID:15840436 PMID:28571686 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression
|
ISO
|
di-n-hexyl phthalate results in increased expression of BAX mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression
|
ISO
|
di-n-hexyl phthalate results in decreased expression of BCL2 mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Casp3
|
caspase 3
|
increases expression
|
ISO
|
di-n-hexyl phthalate results in increased expression of CASP3 mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
increases expression
|
ISO
|
di-n-hexyl phthalate results in increased expression of CASP8 mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Cela3b
|
chymotrypsin like elastase 3B
|
increases expression
|
EXP
|
di-n-hexyl phthalate results in increased expression of ELA3B mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 5:149,628,773...149,636,937
Ensembl chr 5:154,912,170...154,920,333
|
|
G
|
Cpt1b
|
carnitine palmitoyltransferase 1B
|
decreases expression
|
ISO
|
di-n-hexyl phthalate results in decreased expression of CPT1B mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036
|
|
G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of CYP11A1 mRNA; di-n-hexyl phthalate results in decreased expression of CYP11A1 protein
|
CTD |
PMID:22112501 PMID:23754470 PMID:26934186 PMID:33983380 |
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
G
|
Cyp11b2
|
cytochrome P450, family 11, subfamily b, polypeptide 2
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of CYP11B1 mRNA
|
CTD |
PMID:22112501 PMID:33983380 |
|
NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763
|
|
G
|
Cyp11b3
|
cytochrome P450, family 11, subfamily b, polypeptide 3
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of CYP11B2 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921
|
|
G
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of CYP17A1 mRNA; di-n-hexyl phthalate results in decreased expression of CYP17A1 protein
|
CTD |
PMID:22112501 PMID:23754470 PMID:26934186 PMID:33983380 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
|
|
G
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of CYP46A1 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 6:133,011,948...133,039,167
Ensembl chr 6:133,011,989...133,041,971
|
|
G
|
Cyp51
|
cytochrome P450, family 51
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of CYP51 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450
|
|
G
|
Dhcr7
|
7-dehydrocholesterol reductase
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of DHCR7 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382
|
|
G
|
Dhh
|
desert hedgehog signaling molecule
|
increases expression
|
EXP
|
di-n-hexyl phthalate results in increased expression of DHH mRNA; di-n-hexyl phthalate results in increased expression of DHH protein
|
CTD |
PMID:32693021 |
|
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:131,929,857...131,935,352
|
|
G
|
Ebp
|
EBP, cholestenol delta-isomerase
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of EBP mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr X:16,971,372...16,977,782
Ensembl chr X:16,971,405...16,977,781
|
|
G
|
Elovl5
|
ELOVL fatty acid elongase 5
|
decreases expression
|
ISO
|
di-n-hexyl phthalate results in decreased expression of ELOVL5 mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616
|
|
G
|
Esr1
|
estrogen receptor 1
|
affects binding increases expression multiple interactions
|
ISO EXP
|
di-n-hexyl phthalate analog binds to ESR1 protein di-n-hexyl phthalate results in increased expression of ESR1 mRNA di-n-hexyl phthalate binds to and results in increased activity of ESR1 protein; di-n-hexyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR1 protein]; Tamoxifen inhibits the reaction [di-n-hexyl phthalate binds to and results in increased activity of ESR1 protein]
|
CTD |
PMID:15464722 PMID:15840436 PMID:22112501 PMID:28571686 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
G
|
Esr2
|
estrogen receptor 2
|
multiple interactions affects binding
|
ISO
|
di-n-hexyl phthalate binds to and results in decreased activity of ESR2 protein; di-n-hexyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR2 protein] di-n-hexyl phthalate analog binds to ESR2 protein
|
CTD |
PMID:15464722 PMID:15840436 PMID:28571686 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
G
|
Fads2
|
fatty acid desaturase 2
|
decreases expression
|
ISO
|
di-n-hexyl phthalate results in decreased expression of FADS2 mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066
|
|
G
|
Fasn
|
fatty acid synthase
|
decreases expression
|
ISO
|
di-n-hexyl phthalate results in decreased expression of FASN mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
G
|
Fdps
|
farnesyl diphosphate synthase
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of FDPS mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136
|
|
G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
increases phosphorylation
|
EXP
|
di-n-hexyl phthalate results in increased phosphorylation of GSK3B protein
|
CTD |
PMID:32693021 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of HMGCR mRNA
|
CTD |
PMID:26934186 PMID:33983380 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
G
|
Hmgcs1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of HMGCS1 mRNA
|
CTD |
PMID:26934186 PMID:33983380 |
|
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
|
|
G
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of HSD11B1 protein
|
CTD |
PMID:32693021 |
|
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432
|
|
G
|
Hsd17b3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
increases expression
|
EXP
|
di-n-hexyl phthalate results in increased expression of HSD17B3 mRNA
|
CTD |
PMID:26934186 |
|
NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,032,958...1,064,283
|
|
G
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of HSD3B1 mRNA; di-n-hexyl phthalate results in decreased expression of HSD3B1 protein
|
CTD |
PMID:26934186 PMID:32693021 |
|
NCBI chr 2:188,858,574...188,864,694
|
|
G
|
Hsd3b3
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of HSD3B3 mRNA; di-n-hexyl phthalate results in decreased expression of HSD3B3 protein
|
CTD |
PMID:32693021 PMID:33983380 |
|
NCBI chr 2:186,138,044...186,144,024
Ensembl chr 2:188,826,110...188,904,981
|
|
G
|
Idi2l3
|
isopentenyl-diphosphate delta isomerase 2 like 3
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of IDI2L3 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr17:61,518,138...61,535,484
|
|
G
|
Il1b
|
interleukin 1 beta
|
increases expression
|
ISO
|
di-n-hexyl phthalate results in increased expression of IL1B mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Inha
|
inhibin subunit alpha
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of INHA mRNA
|
CTD |
PMID:22112501 PMID:33983380 |
|
NCBI chr 9:84,443,109...84,446,010
Ensembl chr 9:84,443,109...84,446,009
|
|
G
|
Insig1
|
insulin induced gene 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of INSIG1 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
|
|
G
|
Insl3
|
insulin-like 3
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of INSL3 mRNA
|
CTD |
PMID:22112501 PMID:33983380 |
|
NCBI chr16:18,432,668...18,434,539
|
|
G
|
Ldlr
|
low density lipoprotein receptor
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of LDLR mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
G
|
Lhb
|
luteinizing hormone subunit beta
|
increases expression
|
EXP
|
di-n-hexyl phthalate results in increased expression of LHB protein
|
CTD |
PMID:32693021 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
G
|
Lhcgr
|
luteinizing hormone/choriogonadotropin receptor
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of LHCGR mRNA; di-n-hexyl phthalate results in decreased expression of LHCGR protein
|
CTD |
PMID:32693021 PMID:33983380 |
|
NCBI chr 6:11,415,361...11,480,834
Ensembl chr 6:11,415,415...11,478,061
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation
|
EXP
|
di-n-hexyl phthalate results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:32693021 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation
|
EXP
|
di-n-hexyl phthalate results in increased phosphorylation of MAPK3 protein
|
CTD |
PMID:32693021 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mvd
|
mevalonate diphosphate decarboxylase
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of MVD mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr19:67,404,911...67,414,974
Ensembl chr19:67,404,911...67,422,366
|
|
G
|
Nr0b1
|
nuclear receptor subfamily 0, group B, member 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of NR0B1 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr X:54,707,658...54,711,786
Ensembl chr X:54,707,639...54,712,083
|
|
G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
affects binding increases activity
|
ISO
|
di-n-hexyl phthalate binds to NR1I3 protein di-n-hexyl phthalate results in increased activity of NR1I3 protein
|
CTD |
PMID:25938866 PMID:28927721 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
G
|
Nsdhl
|
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of NSDHL mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr X:155,817,301...155,848,224
Ensembl chr X:155,817,340...155,848,220
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
affects binding
|
ISO
|
di-n-hexyl phthalate binds to PPARA protein
|
CTD |
PMID:23843199 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
G
|
Ppard
|
peroxisome proliferator-activated receptor delta
|
affects binding
|
ISO
|
di-n-hexyl phthalate binds to PPARB protein
|
CTD |
PMID:23843199 |
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
affects binding
|
ISO
|
di-n-hexyl phthalate binds to PPARG protein
|
CTD |
PMID:23843199 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of PPARGC1A protein
|
CTD |
PMID:32693021 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
G
|
Rxra
|
retinoid X receptor alpha
|
affects binding
|
ISO
|
di-n-hexyl phthalate binds to RXRA protein
|
CTD |
PMID:23843199 |
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
G
|
Rxrb
|
retinoid X receptor beta
|
affects binding
|
ISO
|
di-n-hexyl phthalate binds to RXRB protein
|
CTD |
PMID:23843199 |
|
NCBI chr20:4,818,707...4,824,968
Ensembl chr20:4,818,709...4,825,359
|
|
G
|
Rxrg
|
retinoid X receptor gamma
|
affects binding
|
ISO
|
di-n-hexyl phthalate binds to RXRG protein
|
CTD |
PMID:23843199 |
|
NCBI chr13:82,276,330...82,318,097
Ensembl chr13:82,276,291...82,318,095
|
|
G
|
Scarb1
|
scavenger receptor class B, member 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of SCARB1 mRNA
|
CTD |
PMID:22112501 PMID:23754470 PMID:26934186 PMID:33983380 |
|
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
|
|
G
|
Shox1
|
SHOX homeobox 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of RHOX10 mRNA
|
CTD |
PMID:22112501 |
|
NCBI chr X:121,553,770...121,560,788
|
|
G
|
Sirt1
|
sirtuin 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of SIRT1 protein
|
CTD |
PMID:32693021 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
G
|
Star
|
steroidogenic acute regulatory protein
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of STAR mRNA
|
CTD |
PMID:22112501 PMID:23754470 PMID:26934186 PMID:33983380 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of TGFB1 mRNA
|
CTD |
PMID:22112501 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tm7sf2
|
transmembrane 7 superfamily member 2
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of TM7SF2 mRNA
|
CTD |
PMID:33983380 |
|
NCBI chr 1:212,785,217...212,789,572
Ensembl chr 1:212,785,217...212,789,557
|
|
G
|
Tnf
|
tumor necrosis factor
|
increases expression
|
ISO
|
di-n-hexyl phthalate results in increased expression of TNF mRNA
|
CTD |
PMID:33043605 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Wnt7a
|
Wnt family member 7A
|
decreases expression
|
EXP
|
di-n-hexyl phthalate results in decreased expression of WNT7A mRNA
|
CTD |
PMID:22112501 PMID:33983380 |
|
NCBI chr 4:125,420,276...125,466,149
Ensembl chr 4:125,420,276...125,466,149
|
|
|
G
|
Edn1
|
endothelin 1
|
increases expression
|
EXP
|
iopromide results in increased expression of EDN1 protein
|
CTD |
PMID:21354280 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
G
|
Hexb
|
hexosaminidase subunit beta
|
increases secretion
|
ISO
|
iopromide results in increased secretion of HEXB protein
|
CTD |
PMID:34774977 |
|
NCBI chr 2:30,218,608...30,238,771
Ensembl chr 2:30,218,608...30,238,771
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases phosphorylation
|
ISO
|
iopromide results in decreased phosphorylation of MAPK1 protein
|
CTD |
PMID:34774977 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases phosphorylation
|
ISO
|
iopromide results in decreased phosphorylation of MAPK3 protein
|
CTD |
PMID:34774977 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mr1
|
major histocompatibility complex, class I-related
|
affects expression
|
ISO
|
iopromide affects the expression of MR1 mRNA
|
CTD |
PMID:25811541 |
|
NCBI chr13:69,850,420...69,868,302
Ensembl chr13:69,850,420...69,868,502
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
decreases expression
|
EXP
|
iopromide results in decreased expression of NOS2 protein
|
CTD |
PMID:21354280 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
RT1-Da
|
RT1 class II, locus Da
|
affects expression
|
ISO
|
iopromide affects the expression of HLA-DRA mRNA
|
CTD |
PMID:25811541 |
|
NCBI chr20:4,515,393...4,520,387
Ensembl chr20:4,513,908...4,520,383
|
|